National Comprehensive Cancer Network



About NCCN

Cervical/Uterine Cancers Panel - Disclosures as of 6/30/2010

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Nadeem R. Abu-Rustum, MD

None

None

None

None

4/17/2014

Sachin M. Apte, MD, MS

None

None

None

None

9/16/2014

Susana M. Campos, MD, MPH, MS

None

None

None

None

12/2/2013

John Chan, MD

None

Ortho Biotech Products, L.P.

None

None

3/27/2013

Kathleen R. Cho, MD

None

None

None

None

5/16/2013

Larry Copeland, MD

None

Bayer HealthCare;
Celgene Corporation;
Eli Lilly and Company;
Precision Therapeutics, Inc.;
sanofi-aventis U.S.

None

Gynecologic Oncology Group

7/20/2014

Marta Ann Crispens, MD

None

None

None

None

5/5/2014

Nefertiti DuPont, MD, MPH

None

None

None

None

4/16/2013

Patricia J. Eifel, MD

None

None

None

None

8/21/2013

David K. Gaffney, MD, PhD

None

None

None

None

4/20/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

12/8/2014

Benjamin E. Greer, MD

None

None

None

None

5/3/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

9/16/2014

Miranda Hughes, PhD

None

None

Myriad Genetic Laboratories, Inc.;
Affymetrix;
Qiagen NV

None

11/7/2014

Warner K. Huh, MD

None

GlaxoSmithKline;
Intuitive Surgical, Inc.;
Merck & Co., Inc.;
Helix BioPharm

None

None

4/24/2014

Daniel S. Kapp, MD, PhD

None

None

None

None

3/24/2011

Wui-Jin Koh, MD

None

None

None

None

5/9/2013

John R. Lurain, MD

None

None

None

None

11/12/2013

Lainie Martin, MD

None

None

None

None

2/4/2014

Joan S. McClure, MS

None

None

None

None

12/8/2014

Nicole McMillian, MS

None

None

None

None

10/8/2014

Mark A. Morgan, MD, FACOG, FACS

None

None

None

None

5/5/2013

Robert J. Morgan, MD, FACP

NIH-CTEP

None

Abbott Laboratories

None

10/20/2014

David Mutch, MD

None

None

None

None

5/1/2014

Steven W. Remmenga, MD

None

None

None

None

5/2/2014

R. Kevin Reynolds, MD

None

None

None

None

8/27/2013

Angeles A. Secord, MD

Bristol-Myers Squibb Company

Abraxis Oncology;
Eli Lilly and Company;
GlaxoSmithKline;
Merck & Co., Inc.;
sanofi-aventis U.S.

None

None

7/20/2010

William Small, MD

None

DOR BioPharma, Inc.

None

None

6/5/2012

Nelson Teng, MD, PhD

None

None

None

None

5/5/2014